Marked prolongation of QRS duration after initiation of dronedarone therapy

Dronedarone is a relatively new antiarrhythmic drug and is held to be less proarrhythmic than comparable compounds, although its proarrhythmia potential in humans has not been sufficiently evaluated. We describe a so far unreported dronedarone effect, namely a significant alteration of both the morp...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Heart Int
Main Authors: Genz, Conrad, Esperer, Hans D., Schmeisser, Alexander, Braun-Dullaeus, Ruediger C., Said, Samir M.
Format: Artigo
Jezik:Inglês
Izdano: Wichtig 2014
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4774943/
https://ncbi.nlm.nih.gov/pubmed/27004096
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki